Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Spectrochim Acta A Mol Biomol Spectrosc ; 136 Pt B: 937-52, 2015 Feb 05.
Article in English | MEDLINE | ID: mdl-25459620

ABSTRACT

Simultaneous determination of mixtures of lidocaine hydrochloride (LH), flucortolone pivalate (FCP), in presence of chlorquinaldol (CQ) without prior separation steps was applied using either successive or progressive resolution techniques. According to the concentration of CQ the extent of overlapping changed so it can be eliminated from the mixture to get the binary mixture of LH and FCP using ratio subtraction method for partially overlapped spectra or constant value via amplitude difference followed by ratio subtraction or constant center followed by spectrum subtraction spectrum subtraction for severely overlapped spectra. Successive ratio subtraction was coupled with extended ratio subtraction, constant multiplication, derivative subtraction coupled constant multiplication, and spectrum subtraction can be applied for the analysis of partially overlapped spectra. On the other hand severely overlapped spectra can be analyzed by constant center and the novel methods namely differential dual wavelength (D(1) DWL) for CQ, ratio difference and differential derivative ratio (D(1) DR) for FCP, while LH was determined by applying constant value via amplitude difference followed by successive ratio subtraction, and successive derivative subtraction. The spectra of the cited drugs can be resolved and their concentrations are determined progressively from the same ratio spectrum using amplitude modulation method. The specificity of the developed methods was investigated by analyzing laboratory prepared mixtures and were successfully applied for the analysis of pharmaceutical formulations containing the cited drugs with no interference from additives. The proposed methods were validated according to the ICH guidelines. The obtained results were statistically compared with those of the official or reported methods; using student t-test, F-test, and one way ANOVA, showing no significant difference with respect to accuracy and precision.


Subject(s)
Pharmaceutical Preparations/analysis , Spectrophotometry/methods , Analysis of Variance , Chlorquinaldol/analysis , Chlorquinaldol/chemistry , Dosage Forms , Lidocaine/analysis , Lidocaine/chemistry , Pharmaceutical Preparations/chemistry
2.
Acta Pol Pharm ; 70(1): 51-8, 2013.
Article in English | MEDLINE | ID: mdl-23610959

ABSTRACT

The study was aimed at developing a simple HPLC method for the determination of the content of impurities in Gynalgin, a two-component preparation. A satisfactory separation was performed on 250 x 4.6 mm Symmetry C8 column in a gradient elution system: mobile phase A--acetonitrile/buffer, pH 5.5 in 10:90, v/v proportion, and mobile phase B--acetonitrile/buffer, pH 5.5 in 75:25 v/v proportion. Two wavelengths: 250 nm and 315 nm were used for detection. Validation confirmed that the method was linear in a required concentration range. The values of correlation coefficients for specific drug substances and the related impurities were as high as 0.999. The results of the purity tests proved that the method was sufficiently selective and precise.


Subject(s)
Anti-Infective Agents/analysis , Chlorquinaldol/analysis , Chromatography, High Pressure Liquid , Drug Contamination , Metronidazole/analysis , Acetonitriles/chemistry , Anti-Infective Agents/standards , Buffers , Calibration , Chlorquinaldol/standards , Chromatography, High Pressure Liquid/standards , Drug Combinations , Hydrogen-Ion Concentration , Limit of Detection , Linear Models , Metronidazole/standards , Quality Control , Reference Standards , Reproducibility of Results , Spectrophotometry, Ultraviolet , Tablets
3.
J Pharm Biomed Anal ; 14(11): 1505-11, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8877856

ABSTRACT

A reliable and highly sensitive method is described for the determination of chloroxine in pharmaceutical preparations. It involves the formation of a complex between chloroxine and aluminum(III) in a micellar medium. The complex is a very fluorescent species, and there is a linear relationship between chloroxine concentration and fluorescence intensity over the range 2.0 x 10(-8)-5.1 x 10(-5) mol l-1. The limit of detection is 5 x 10(-9) mol l-1. The method can be easily adapted to a flow system using a three-channel manifold, the peak height being proportional to the chloroxine concentration over the range 5.6 x 10(-7)-5.6 x 10(-5) mol l-1. Manual and flow-injection procedures permit the determination of chloroxine in the presence of chlorquinaldol, and have been successfully applied to the determination of chloroxine in pharmaceutical preparations.


Subject(s)
Aluminum/chemistry , Amebicides/analysis , Chloroquinolinols/analysis , Chlorquinaldol/analysis , Fluorometry/methods , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...